Riskpilot← Back to searchSign inGet full accessCONTINENCE CARE ApS
APSActiveCVR 28287054Bybjergvej 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20041 employees
Revenue 2024
DKK -546K
-240% vs 2023
EBITDA margin
100.0%
-240% vs 2023
Equity ratio
-98.1%
Financial strength
Net profit 2024
DKK -137K
-145% vs 2023
| Revenue | DKK -546K | -240% |
| EBITDA | DKK -546K | -240% |
| Net profit | DKK -137K | -145% |
| Total assets | DKK 1,3M | -36% |
| Equity | DKK -1,3M | -12% |
| Employees | 1 | — |
Legal name
CONTINENCE CARE ApS
CVR number
28287054
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. august 2004
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør.
Company purpose
Selskabets formål er at være distributør og producent af inkontinensprodukter og medicinske katetre til hospitals- og hjemmeplejesektoren samt at servicere relevante målgrupper via disse sektorer tillige med anden hermed forbunden virksomhed. Hertil videre at foretage inve-steringer i andre selskaber med sigte på forretningsmæssig og produktmæssig udvikling samt anden virksomhed, der står i forbindelse hermed.
Address
Bybjergvej 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -4 | 539 | 754 | — | 1.280 | 501 | 1.198 | 899 | -301 | 349 | 443 | 390 | -546 |
| Staff expenses | -85 | -147 | -132 | -10 | -2 | -0 | -167 | -110 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -1.457 | 392 | 622 | -375 | 1.278 | 501 | 1.031 | 789 | -1.171 | 349 | 443 | 390 | -546 |
| Depreciation & amort. | 36 | 68 | -95 | -78 | -496 | -268 | -264 | -192 | -324 | -31 | -0 | -0 | -0 |
| EBIT | -1.494 | 324 | 527 | -453 | 782 | 232 | 767 | 597 | -1.496 | 318 | 443 | 390 | -546 |
| Net financials | -177 | -181 | -150 | -316 | -163 | 9 | -262 | -333 | -136 | -144 | -124 | -4 | 400 |
| Profit before tax | -1.670 | 143 | 378 | -769 | 619 | 241 | 505 | 264 | -1.632 | 174 | 319 | 386 | -146 |
| Tax | -0 | -144 | 114 | -168 | 137 | 54 | 114 | 59 | -358 | 38 | 71 | 85 | -10 |
| Net profit | -1.670 | 287 | 263 | -601 | 482 | 187 | 391 | 205 | -1.274 | 136 | 248 | 301 | -137 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.090 | 3.373 | 6.747 | 4.626 | 4.862 | 7.267 | 5.628 | 4.255 | 4.281 | 5.852 | 1.922 | 2.003 | 1.275 |
| Equity | -2.844 | -2.557 | -2.294 | -2.895 | -2.413 | -2.226 | -1.834 | -1.630 | -1.799 | -1.663 | -1.415 | -1.114 | -1.250 |
| Long-term debt | 3.224 | 3.994 | 3.892 | 4.733 | 3.288 | 2.114 | 1.502 | 2.704 | 2.435 | 995 | 2.095 | 1.342 | 1.055 |
| Short-term debt | 1.710 | 1.936 | 5.149 | 2.787 | 3.987 | 7.379 | 5.961 | 3.180 | 3.645 | 6.520 | 1.241 | 1.774 | 1.471 |
| Total debt | 4.934 | 5.930 | 9.041 | 7.521 | 7.275 | 9.493 | 7.463 | 5.884 | 6.080 | 7.515 | 3.336 | 3.117 | 2.525 |
EBITDA margin
-54618800.0%
This company
15.8%
Market median
-345688708% vs market
20122024
Equity ratio
-98.1%
This company
38.2%
Market median
-357% vs market
20122024
Return on equity
-13664300.0%
This company
18.4%
Market median
-74262600% vs market
20122024
Net profit margin
-13664300.0%
This company
8.1%
Market median
-168695162% vs market
20122024
Asset turnover
-0.43×
This company
1.12×
Market median
-138% vs market
20122024
Debt / equity
2.02×
This company
0.62×
Market median
-226% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FS Management | Management | 2004 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2004 | — | — | |
| Chairman | 2009 | — | — | |
| Chairman | 2004 | — | — | |
| Board of Directors | 2009 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Sherwood Capital ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sherwood Capital ApS
CONTINENCE CARE ApS Board members of CONTINENCE CARE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Flemming Steen Andersen | Management | 0 companies |
| Helle Jørgsholm | Board of Directors | 0 companies |
| Bjarne Werner Munck | Board of Directors | 0 companies |
| Henrik Gynde Kany | Chairman | 0 companies |
| Sten Verland | Chairman | 0 companies |
| Bent Høj Andersen | Board of Directors | 0 companies |